
Shift Bioscience raised $16M to advance research into better drugs for aging-related disease
Shift Bioscience has secured $16 million in seed funding to advance the AI-powered cell simulation platform which supports its mission to identify gene activations that can safely trigger cell rejuvenation and serve as the basis for treatments for age-related diseases.